参考文献/References:
[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016 [J]. CACancer J Clin, 2016, 66(1): 7-30.
[2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China,2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
[3] Zhang L, Wu S, Guo LR, et al. Diagnostic strategies and theincidence of prostate cancer: reasons for the low reportedincidence of prostate cancer in China[J]. Asian J Androl, 2009, 11(1): 9-13.
[4] Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion ofTMPRSS2 and ETS transcription factor genes in prostate cancer[J]. Science, 2005, 310(5748): 644-648.
[5] Clark JP, Cooper CS. ETS gene fusions in prostate cancer [J]. NatRev Urol, 2009, 6(8): 429-439.
[6] Rachidi M, Delezoide AL, Delabar JM, et al. A quantitativeassessment of gene expression (QAGE) reveals differentialoverexpression of Dopey2, a candidate gene for mentalretardation, in Down syndrome brain regions [J]. Int J DevNeurosci, 2009, 27(4): 393-398.
[7] Scheble VJ, Braun M, Beroukhim R, et al. ERG rearrangement isspecific to prostate cancer and does not occur in any othercommon tumor[J]. Mod Pathol, 2010, 23(8): 1061-1067.
[8] Park K, Tomlins SA, Mudaliar KM, et al. Antibody-baseddetection of ERG rearrangement-positive prostate cancer [J].Neoplasia, 2010, 12(7): 590-598.
[9] Sun QP, Li LY, Chen Z, et al. Detection of TMPRSS2-ETSfusions by a multiprobe fluorescence in situ hybridization assayfor the early diagnosis of prostate cancer: a pilot study [J]. J MolDiagn, 2010, 12(5): 718-724.
[10] Gao X, Li LY, Zhou FJ, et al. ERG rearrangement for predictingsubsequent cancer diagnosis in high-grade prostatic intraepithelialneoplasia and lymph node metastasis [J]. Clin Cancer Res, 2012,18(15): 4163-4172.
[11] Mikhaylenko DS, Perepechin DV, Grigoryeva MV, et al. PCA3and TMPRSS2: ERG genes expression in biopsies of benignprostate hyperplasia, intraepithelial neoplasia, and prostate cancer[J].Urologiia, 2015, (5): 46-50.
[12] Sanguedolce F, Cormio A, Brunelli M, et al. Urine TMPRSS2:ERG fusion transcript as a biomarker for prostate cancer: literaturereview[J]. Clin Genitourin Cancer, 2016,14(2): 117-121.
[13] Rachidi M, Lopes C, Costantine M, et al. C21orf5, a new memberof Dopey family involved in morphogenesis, could participate inneurological alterations and mental retardation in Down syndrome[J]. DNA Res, 2005, 12(3): 203-210.
[14] Bj觟rklund M, Taipale M, Varjosalo M, et al. Identification ofpathways regulating cell size and cell-cycle progression by RNAi[J]. Nature, 2006, 439(779): 1009-1013.
[15] Bismar TA, Dolph M, Teng LH, et al. ERG protein expressionreflects hormonal treatment response and is associated withGleason score and prostate cancer specific mortality [J]. Eur JCancer, 2012, 48(4): 538-546.[0
相似文献/References:
[1]李辽源,高新,李解方,等.血清/尿PSA比值对血清PSA处于"灰区"中前列腺癌的诊断价值[J].中华腔镜泌尿外科杂志(电子版),2008,(03):52.
LI Liao-yuan,GAO Xin,LI Xie-fang,et al.The role of the ratio of serum PSA and urine PSA in diagnosing prostate carcinoma within the serum PSA "gray" zone[J].,2008,(02):52.
[2]仲飞,郝吉庆,孙国平.多西他赛联合卡培他滨治疗激素抵抗性晚期前列腺癌的近期疗效[J].中华腔镜泌尿外科杂志(电子版),2011,(04):278.
ZHONG Fei,HAO Jiqing,SUN Guo-ping.Effects of docetaxel and capecitabine for hormone-refractory prostate cancer[J].,2011,(02):278.
[3]何必鸣,陈锐,高旭,等.前列腺癌术后病理较穿刺病理Gleason 评分升高的相关因素[J].中华腔镜泌尿外科杂志(电子版),2016,10(02):77.[doi:10.3877/cma.j.issn.1674-3253.2016.02.002]
[4]周骏,梁朝朝,施浩强,等.腹腔镜前列腺癌根治术的技术改良与再认识[J].中华腔镜泌尿外科杂志(电子版),2016,10(02):80.[doi:10.3877/cma.j.issn.1674-3253.2016.02.003]
[5]施振凯,高旭,王海峰,等.机器人辅助筋膜内前列腺癌根治术对术后尿控影响的研究[J].中华腔镜泌尿外科杂志(电子版),2016,10(01):8.[doi:10.3877/cma.j.issn.1674-3253.2016.01.003
]
Shi Zhenkai,Gao Xu,Wang Haifeng,et al.Urinary function of intrafascial robot-assisted laparoscopic radical prostatectomy[J].,2016,10(02):8.[doi:10.3877/cma.j.issn.1674-3253.2016.01.003
]
[6]林立国,吴国忠,孙忠凯,等.经尿道前列腺电切术诊治高度疑似晚期前列腺癌并膀胱出口梗阻[J].中华腔镜泌尿外科杂志(电子版),2016,10(04):230.[doi:10.3877/cma.j.issn.1674-3253.2016.04.004
]
Lin Liguo,Wu Guozhong,Sun Zhongkai,et al.Transurethral resection of prostate to diagnose and treat the patients with highly suspected advanced prostate cancer and lower urinary tract symptoms[J].,2016,10(02):230.[doi:10.3877/cma.j.issn.1674-3253.2016.04.004
]
[7]杨波 邓晓俊 温晓飞 陈卫华 刘辉 刘峰 王伟峰 郝继东 万建省 廖国强.经直肠弹性超声穿刺活检联合墨水标记法病理诊断前列腺癌的研究[J].中华腔镜泌尿外科杂志(电子版),2016,10(05):296.[doi:10.3877/cma.j.issn.1674-3253.2016.05.002
]
Yang Bo,DengXiaojun,WenXiaofei,et al.The clinical research of biopsy of prostate cancer by transrectal ultrasound elastography combined ink marking[J].,2016,10(02):296.[doi:10.3877/cma.j.issn.1674-3253.2016.05.002
]
[8]杨逢生,李宝兴,刘文泓,等.经腹与经腹膜外途径腹腔镜前列腺癌根治术疗效比较的Meta分析[J].中华腔镜泌尿外科杂志(电子版),2016,10(05):301.[doi:10.3877/cma.j.issn.1674-3253.2016.05.003
]
Yang Fengsheng,Li Baoxing,Liu Wenhong,et al.Comparison of transperitoneal and extraperitoneal laparoscopic radical prostatectomy: a Meta analysis[J].,2016,10(02):301.[doi:10.3877/cma.j.issn.1674-3253.2016.05.003
]
[9]赖义明 钟娴 陈贤举 袁立燕 章颖 郑瑞映 谢鸿玉 王昕 黄海 郭正辉.前列腺癌血管形成机制研究进展[J].中华腔镜泌尿外科杂志(电子版),2016,10(06):423.[doi:10.3877/cma.j.issn.1674-3253.2016.06.014
]
[10]曹达龙 叶定伟 戴波 张海梁 沈益君 朱一平 施国海 马春光 肖文军 秦晓健 林国文 朱耀.腹腔镜前列腺癌根治术时对腺体突向膀胱的优化处理:附视频[J].中华腔镜泌尿外科杂志(电子版),2015,(05):317.[doi:10.3877/cma.j.issn.1674-3253.2015.05.002
]
Cao Dalong,Ye Dingwei,et al.The optimized treatment of prostate gland protruding to bladder in laparoscopic radical prostatectomy[J].,2015,(02):317.[doi:10.3877/cma.j.issn.1674-3253.2015.05.002
]